Virginia Borges
Professor, Medicine-Medical Oncology · University of Colorado
Credentials: · ·
History
Present
- Until 1996
Deaconess Hospital Program
- Until 1994
Deaconess Hospital Program
Research
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
New England Journal of Medicine · 2020 · 1,022 citations
Journal of Clinical Oncology · 2020 · 452 citations
Journal of Clinical Oncology · 2020 · 348 citations
63 papers
55 papers
51 papers
50 papers
32 papers
20 papers · 2 as a fellow
19 papers
19 papers
Grants
- 2000–2029
Paul Calabresi Award in Clinical Oncology Research
National Cancer Institute · K12
Contact PI · $6M · University of Colorado Denver
- 2024–2029
A SIM2s/SEMA7A Switch Drives ER+ Breast Cancer Progression
National Cancer Institute · R01
PI · $1.7M · University of Colorado Denver
- 2013–2019
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
National Cancer Institute · R01
PI · $2.9M · Oregon Health & Science University
Clinical trials
- 2015–2037
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Principal investigator · Recruiting
University of Colorado, Denver
- 2009–2015
Window of Opportunity Study Targeting the Inflammatory Milieu
Principal investigator · Completed · Early phase 1
University of Colorado, Denver
- 2009–2027
The Immune System's Response to Young Women's Breast Cancer
Principal investigator · Recruiting
University of Colorado, Denver
- 2006–2035
The Young Women's Breast Cancer Study
Principal investigator · Active not recruiting
Dana-Farber Cancer Institute